These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Advances in the identification of the aetiology of mental retardation].
    Author: González G, Raggio V, Boidi M, Tapié A, Roche L.
    Journal: Rev Neurol; 2013 Sep 06; 57 Suppl 1():S75-83. PubMed ID: 23897159.
    Abstract:
    Despite the advances made in the field of genetics, neuroimaging and metabolic diseases, half the children with mental retardation remain without an aetiological diagnosis. A genetic base is estimated to be present in 40% of cases, environmental teratogens and prematurity in 20%, metabolic diseases in 1-5% and multifactor causes in 3-12%. The family history, the detailed medical records required by dysmorphology and the neurological examination will make it possible to establish or suspect a diagnosis in two thirds of the cases and, in the others, scanning tests will be able to confirm an aetiology. The order of the studies will be guided by the clinical picture: karyotype if a chromosome pathology is suspected, neuroimaging if there is some abnormality in the neurological examination and specific genetic or neurometabolic studies to confirm the clinical presumption. The estimated diagnostic performance of the different techniques is: karyotype, 9%; fragile X, 5%; subtelomeric abnormalities, 4%; neurometabolic diseases, 1%, and new microarray techniques, 19%. As a result of the higher performance and cost-benefit ratio, today the recommended procedure, as the first line of treatment for unexplainable cases of mental retardation, is the study of microarrays. Although the outcomes of these tests are complex and require confirmation and careful interpretation by a specialist in medical genetics, the advances in their technological development and resolution, together with lower costs make this technique a fundamental tool in the identification of the aetiology in these children. TITLE: Avances en la identificacion etiologica del retraso mental. UNLABELLED: A pesar de los avances en el campo de la genetica, la neuroimagen y las enfermedades metabolicas, la mitad de los niños con retraso mental permanecen sin diagnostico etiologico. Se estima una base genetica en un 40% de los casos, teratogenos ambientales y prematuridad en un 20%, enfermedades metabolicas en un 1-5% y causas multifactoriales en un 3-12%. Los antecedentes familiares, la historia clinica detallada que precisa la dismorfologia y el examen neurologico permitiran establecer o sospechar un diagnostico en dos tercios de los casos y, en los restantes, las pruebas de barrido podran confirmar una etiologia. El orden de los estudios guiara la clinica: cariotipo si se sospecha de cromosomopatia, neuroimagen si existe una alteracion del examen neurologico y estudios geneticos especificos o neurometabolicos para confirmar la presuncion clinica. El rendimiento diagnostico estimado de las diferentes tecnicas es: cariotipo, 9%; X fragil, 5%; anomalias subtelomericas, 4%; enfermedades neurometabolicas, 1%, y nuevas tecnicas de microarrays, 19%. Debido al mayor rendimiento y coste-beneficio, actualmente se recomienda, como primera linea para los retrasos mentales inexplicables, los estudios de microarrays. Si bien los resultados de estas pruebas son complejos y requieren confirmacion e interpretacion cuidadosa de un especialista en genetica medica, los avances en su desarrollo tecnologico, resolucion y disminucion de los costes determinan que se transforme en una herramienta fundamental en la identificacion etiologica de estos niños.
    [Abstract] [Full Text] [Related] [New Search]